BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11105778)

  • 1. TNF-alpha blockade by a dimeric TNF type I receptor molecule selectively inhibits adaptive immune responses.
    Colagiovanni DB; Suniga MA; Frazier JL; Edwards CK; Fleshner M; McCay JA; White KL; Shopp GM
    Immunopharmacol Immunotoxicol; 2000 Nov; 22(4):627-51. PubMed ID: 11105778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor (TNF) receptor shedding controls thresholds of innate immune activation that balance opposing TNF functions in infectious and inflammatory diseases.
    Xanthoulea S; Pasparakis M; Kousteni S; Brakebusch C; Wallach D; Bauer J; Lassmann H; Kollias G
    J Exp Med; 2004 Aug; 200(3):367-76. PubMed ID: 15289505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
    Corcoran AE; Scallon BJ; Trinh H; Chernajovsky Y; Ghrayeb J; Feldmann M
    Eur Cytokine Netw; 1998 Sep; 9(3):255-62. PubMed ID: 9831174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional regulation of the biological effects of TNF-alpha by the soluble type I and type II TNF receptors.
    Hale KK; Smith CG; Baker SL; Vanderslice RW; Squires CH; Gleason TM; Tucker KK; Kohno T; Russell DA
    Cytokine; 1995 Jan; 7(1):26-38. PubMed ID: 7749064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation.
    Peschon JJ; Torrance DS; Stocking KL; Glaccum MB; Otten C; Willis CR; Charrier K; Morrissey PJ; Ware CB; Mohler KM
    J Immunol; 1998 Jan; 160(2):943-52. PubMed ID: 9551933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor (TNF)-induced cutaneous necrosis is mediated by TNF receptor 1.
    Amar S; Van Dyke TE; Eugster HP; Schultze N; Koebel P; Bluethmann H
    J Inflamm; 1995-1996; 47(4):180-9. PubMed ID: 9144075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor (TNF) receptor type 1 (p55) is a main mediator for TNF-alpha-induced skin inflammation.
    Kondo S; Sauder DN
    Eur J Immunol; 1997 Jul; 27(7):1713-8. PubMed ID: 9247582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of TNF by a TNF receptor immunoadhesin. Comparison to an anti-TNF monoclonal antibody.
    Haak-Frendscho M; Marsters SA; Mordenti J; Brady S; Gillett NA; Chen SA; Ashkenazi A
    J Immunol; 1994 Feb; 152(3):1347-53. PubMed ID: 8301136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential requirements for soluble and transmembrane tumor necrosis factor in the immunological control of primary and secondary Listeria monocytogenes infection.
    Musicki K; Briscoe H; Tran S; Britton WJ; Saunders BM
    Infect Immun; 2006 Jun; 74(6):3180-9. PubMed ID: 16714545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respective roles of TNF-alpha and IL-6 in the immune response-elicited by adenovirus-mediated gene transfer in mice.
    Benihoud K; Esselin S; Descamps D; Jullienne B; Salone B; Bobé P; Bonardelle D; Connault E; Opolon P; Saggio I; Perricaudet M
    Gene Ther; 2007 Mar; 14(6):533-44. PubMed ID: 17109009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria.
    Lucas R; Juillard P; Decoster E; Redard M; Burger D; Donati Y; Giroud C; Monso-Hinard C; De Kesel T; Buurman WA; Moore MW; Dayer JM; Fiers W; Bluethmann H; Grau GE
    Eur J Immunol; 1997 Jul; 27(7):1719-25. PubMed ID: 9247583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signaling.
    Alexopoulou L; Pasparakis M; Kollias G
    Eur J Immunol; 1997 Oct; 27(10):2588-92. PubMed ID: 9368614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2.
    Reinhard C; Shamoon B; Shyamala V; Williams LT
    EMBO J; 1997 Mar; 16(5):1080-92. PubMed ID: 9118946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of collagen-induced arthritis in 55-kDa TNF receptor type 1 (TNFR1)-IgG1-treated and TNFR1-deficient mice.
    Mori L; Iselin S; De Libero G; Lesslauer W
    J Immunol; 1996 Oct; 157(7):3178-82. PubMed ID: 8816431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour necrosis factor, but not interferon-gamma, is essential for acquired resistance to Listeria monocytogenes during a secondary infection in mice.
    Samsom JN; Langermans JA; Savelkoul HF; van Furth R
    Immunology; 1995 Oct; 86(2):256-62. PubMed ID: 7490127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF receptor I mediates chemokine production and neutrophil accumulation in the lung following systemic lipopolysaccharide.
    Calkins CM; Heimbach JK; Bensard DD; Song Y; Raeburn CD; Meng X; McIntyre RC
    J Surg Res; 2001 Dec; 101(2):232-7. PubMed ID: 11735280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes.
    Rothe J; Lesslauer W; Lötscher H; Lang Y; Koebel P; Köntgen F; Althage A; Zinkernagel R; Steinmetz M; Bluethmann H
    Nature; 1993 Aug; 364(6440):798-802. PubMed ID: 8395024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The functional role of 55- and 75-kDa tumour necrosis factor receptors in human polymorphonuclear cells in vitro.
    Abe Y; Osuka Y; Nakata T; Kashu Y; Kimura S
    Cytokine; 1995 Jan; 7(1):39-49. PubMed ID: 7749065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trophoblastic cell lines generated from tumour necrosis factor receptor-deficient mice reveal specific functions for the two tumour necrosis factor receptors.
    Rasmussen CA; Pace JL; Banerjee S; Phillips TA; Hunt JS
    Placenta; 1999; 20(2-3):213-22. PubMed ID: 10195744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists.
    Mohler KM; Torrance DS; Smith CA; Goodwin RG; Stremler KE; Fung VP; Madani H; Widmer MB
    J Immunol; 1993 Aug; 151(3):1548-61. PubMed ID: 8393046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.